In patients with pN1 PCa, restaging PSMA‐PET/CT at early BCR identified newly detected metastatic disease in nearly half of patients, whereof half were limited to the pelvis and a quarter showed distant metastases. This evidence concerns the gene FOLH1 and metastatic neoplasm.